A previous study proposed that FABP4 suppresses hepatocellular carcinoma cell proliferation and invasion in vitro and decreases tumor volume in vivo, suggesting that FABP4 could be a potential therapeutic target for cancer [37]. This evidence concerns the gene FABP4 and hepatocellular carcinoma.